Location History:
- Wuppertal, DE (2016)
- Berlin, DE (2016 - 2017)
Company Filing History:
Years Active: 2016-2017
Title: Christiane Otto: Innovator in Prolactin Receptor Antibody Research
Introduction
Christiane Otto is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of prolactin receptor antibodies. With a total of 4 patents to her name, her work has the potential to impact various therapeutic areas.
Latest Patents
One of her latest patents is titled "Neutralizing prolactin receptor antibody Mat3 and its therapeutic use." This invention focuses on the neutralizing prolactin receptor antibody Mat3, along with its antigen-binding fragments and pharmaceutical compositions. The patent outlines its use in treating or preventing benign disorders mediated by the prolactin receptor, including endometriosis, adenomyosis, non-hormonal female contraception, and more. The antibody effectively blocks prolactin receptor-mediated signaling, offering new avenues for treatment.
Another significant patent is "Neutralizing prolactin receptor antibodies and their therapeutic use." This invention pertains to the neutralizing prolactin receptor antibody 006-H08 and its matured forms. Similar to her previous patent, it addresses the treatment and prevention of benign disorders linked to the prolactin receptor. The antibodies described in this patent also block prolactin receptor-mediated signaling, reinforcing the therapeutic potential of her research.
Career Highlights
Christiane Otto is currently associated with Bayer Intellectual Property GmbH, where she continues her innovative work in biotechnology. Her research has garnered attention for its potential applications in various medical fields, particularly in women's health.
Collaborations
Throughout her career, Christiane has collaborated with notable colleagues, including Christoph Freiberg and Axel Harrenga. These partnerships have contributed to the advancement of her research and the development of her patents.
Conclusion
Christiane Otto is a trailblazer in the field of prolactin receptor antibody research. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving therapeutic options for patients.